AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (1.1 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

NRF2 participates in the suppressive tumor immune microenvironment of KRAS/KEAP1 co-mutant non-small cell lung cancer by inhibiting the STING pathway

Sun Xiaodana,, Zhao Peiyana, Li Huib, Liu Yanb, Cheng Yingc ( )
Postdoctoral Research Workstation, Jilin Cancer Hospital, Changchun, Jilin 130012, China
Translational Cancer Research, Jilin Cancer Hospital, Changchun, Jilin 130012, China
Department of Medical Thoracic Oncology, Jilin Cancer Hospital, Changchun, Jilin 130012, China

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

1

Skoulidis F, Heymach JV. Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy. Nat Rev Cancer. 2019;19(9):495-509.
Crossref Google Scholar
2

Cai MC, Chen M, Ma P, et al. Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2-mutant lung cancer. Int J Cancer. 2019;144(4):788-801.
Crossref Google Scholar
3

Do HTT, Lee CH, Cho J. Chemokines and their receptors: multifaceted roles in cancer progression and potential value as cancer prognostic markers. Cancers. 2020;12(2):287.
Crossref Google Scholar
4

Sen T, Rodriguez BL, Chen L, et al. Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer. Cancer Discov. 2019;9(5):646-661.
Crossref Google Scholar
5

Haag SM, Gulen MF, Reymond L, et al. Targeting STING with covalent small-molecule inhibitors. Nature. 2018;559(7713):269-273.
Crossref Google Scholar
Genes & Diseases
Volume 10 Issue 5,
September 2023
Pages 1727-1730
DOI: 10.1016/j.gendis.2022.10.009
Cite this article:
Xiaodan S, Peiyan Z, Hui L, et al. NRF2 participates in the suppressive tumor immune microenvironment of KRAS/KEAP1 co-mutant non-small cell lung cancer by inhibiting the STING pathway. Genes & Diseases, 2023, 10(5): 1727-1730. https://doi.org/10.1016/j.gendis.2022.10.009

238

Views

3

Downloads

2

Crossref

3

Web of Science

3

Scopus

0

CSCD

Altmetrics
Received: 24 March 2022
Published: 25 October 2022
© 2022 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Return